MTS Medication Tech. (MTSI) Reports Q3 Earnings
MTS Medication Technologies, Inc. (Nasdaq: MTSI) reports Q3 EPS of $0.10, compared to $0.09 in the same quarter last year. Revenue for the quarter was $19.2 million, versus the consensus of $20.70 million.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
